Russell A. Lewthwaite

Design and Synthesis of Inhaled p38 Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease

David S. Millan, Mark E. Bunnage, Jane L. Burrows et al. · Journal of Medicinal Chemistry · 2011 · 95 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Utilization of an Intramolecular Hydrogen Bond To Increase the CNS Penetration of an NK₁ Receptor Antagonist

Valerie A. Ashwood, Mark J. Field, David C. Horwell et al. · Journal of Medicinal Chemistry · 2001 · 79 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Inhalation by Design: Novel Ultra-Long-Acting β₂-Adrenoreceptor Agonists for Inhaled Once-Daily Treatment of Asthma and Chronic Obstructive Pulmonary Disease That Utilize a Sulfonamide Agonist Headgroup

Paul A. Glossop, Charlotte A. L. Lane, David Price et al. · Journal of Medicinal Chemistry · 2010 · 74 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Tagged phosphine reagents to assist reaction work-up by phase-switched scavenging using a modular flow reactor

Christopher D. Smith, Ian R. Baxendale, Geoffrey K. Tranmer et al. · Organic & Biomolecular Chemistry · 2007 · 57 citations · Full text

Engineering, Chemical Engineering, Chemistry +5

PD 176252 — The first high affinity non-peptide gastrin-releasing peptide (BB2) receptor antagonist

Valerie A. Ashwood, Varuni R. Brownhill, Michael Higginbottom et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 50 citations · Full text

Medicine, Endocrinology, Pharmacology +10